Lancet study reported a research online which says that the two shot vaccine developed in Russia had a great immune response. The Russian vaccine for coronavirus was developed by Gamaleya Research Institute. The research showed that the vaccine was safe and does not cause serious adverse effects in healthy adult volunteers.

“We are in close dialogue, agreements with certain companies in India. We appreciate that they didn’t ‘attack’ the vaccine but carefully sought to understand its mechanism of action. We are very grateful to India for the openness shown,” -Kirill Dmitriev (CEO of Russian Direct Investment Fund )

The vaccine consists of two components, a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (rAd5) vector, both carrying the gene for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein (rAd26-S and rAd5-S).

Russian scientists have begun with the Phase-3 trials of the vaccine in 40,000 volunteers, results are likely to be known publicly by the month of November.